Milategrast

N/A

Report date: 2024/08/16 20:00:38
NME

Base Information

Drug NameMilategrast
Drug Alias NameE-6007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin antagonists
TargetsIntegrin
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEa Pharma Co LtdEisai IncEisai Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A